UnitedHealth Group (UNH) Tops Q1 EPS by 9c; Boosts FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
FBR Capital Reiterates Outperform on UnitedHealth Group (UNH) Following 1Q Results
April 20, 2016 8:57 AM EDTFBR Capital maintained an Outperform rating and $145.00 price target on UnitedHealth Group (NYSE: UNH) following the company's 1Q earnings report. Results continue to be affected by last year's acquisition of Catamaran. Still, segment organic revenue growth was 11% on a year-over-year basis, OptumHealth revenue grew 22%, and OptumInsight revenue grew 20%. UNH indicates that it saw growth in small- to... More
Mizuho Securities Says UnitedHealth Group (UNH) Remains 'Largely Misunderstood' - PT to $156 Following 1Q
April 20, 2016 7:56 AM EDTMizuho Securities reiterated a Buy rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $156.00 (from $150.00), following the company's 1Q earnings report. Guidance is up $0.15 to a range for adjusted EPS of $7.75 to $7.95.
Analyst Sheryl Skolnick commented, "UNH remains largely... More
Leerink Keeps UnitedHealth (UNH) at 'Outperform' Following Q1 Results; Says Overall Performance was 'Very Strong'
April 19, 2016 8:41 AM EDTLeerink affirms UnitedHealth (NYSE: UNH) with an Outperform rating and $150 price target following the company's Q1 report and boosted outlook issued earlier Tuesday.
Analyst Ana Gupte offered the following commentary: The EPS beat was driven by a) favorable tax treatment, b) better than expected... More
